Sumin Koo
Healthcare Executive I Strategy Consultant McKinsey
- Role
- Director at Marwood Group
- Location
- Seattle, WA, US
- LinkedIn followers
- 500 followers
About Sumin Koo
Sumin Koo, Ph.D. is a senior healthcare executive and strategic advisor. She combines strategic consulting and operational executive experience, grounded in a rigorous scientific background. She began her career at McKinsey & Co.’s healthcare practice, serving pharma and biotech clients on Merger & Acquisitions and R&D. She then joined Novartis, leading a cross-functional team to deliver late-stage clinical trials, shepherded the asset through approval for FDA Biologics License Application, and prepared for product launch. Sumin became Vice President of Haemonetics, a $4B medical device public company. She worked as Chief of Staff to the CEO in a turnaround, supporting Board of Director meetings, investor communications, and special projects outside reporting lines. Sumin joined Bill and Melinda Gates Foundation as Deputy Director for the Innovative Technologies Solutions group. She was mobilized in the Foundation’s COVID response to poor regions. Key actions included Dx CEO Roundtable with NIH, partnering with Clinton Health Access Initiative on a volume guarantee deal, and participating in WHO’s COVID-19 accelerator. She led the due diligence for impact investors (Soros Economic Development Fund and 2 family offices) that resulted in an £80M acquisition of a distressed diagnostic company to preserve its neglected diseases assets. She was appointed by the NewCo’s Board to be its interim CEO. In that capacity, she onboarded an external CFO to drive clarity into the financials, developed options for its sustainability, and aid its transition into a dual-mission entity that is financially independent and impact focused. Sumin was trained in cancer genetics, under the sponsorship from the Agency of Science, Technology and Research of Singapore. She earned her Ph.D. studying the genetics of leukemia at Harvard Medical School. She graduated from University of Cambridge, as a Glaxo-Wellcome Scholar, with a B.A. in Biochemistry.
Experience
Director
Jan 2025 — Present
Education
Harvard University
Ph.D., Cancer Genetics
2004 — 2009
University of Cambridge
BA, MA, Biochemistry
2000 — 2003
Skills
- Financial Modeling
- Strategy
- Business Strategy
- Pharmaceutical Industry
- Business Development
- Biotechnology
- Corporate Development
- Lifesciences
- Clinical Trials
- Program Management
- Mergers & Acquisitions
- Oncology
- Clinical Development
- Life Sciences
- Management Consulting
- Management
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.